Position Summary

The Molecular Imaging and Radiotheranostics (MIRA) laboratory is hiring a research specialist to work on projects investigating the tumor radiobiology and immunomodulation of radiopharmaceutical theranostic agents. This individual will lead the design and execution of studies looking at the phenotypic and genomic effects of different radiopharmaceuticals on cancer cells to identify mechanisms of sensitivity or resistance, leading to a more effective single agent or combination therapies.

Job duties:

The Molecular Imaging and Radiotheranostics (MIRA) laboratory focuses on developing radiopharmaceuticals for imaging and therapy with a focus on tumor microenvironment modulation. Within this topic, the selected candidate will work on projects investigating the tumor radiobiology and immunomodulation of radiopharmaceutical theranostic agents. This individual will lead the design and execution of studies looking at the phenotypic and genomic effects of different radiopharmaceuticals on cancer cells to identify mechanisms of sensitivity or resistance, leading to a more effective single agent or combination therapies. The selected candidate is expected to perform and analyze in vitro radiobiological assays such as clonogenic and survival assays, comet assays, RNA sequencing, western blot, histology, gene transfections, and microscopy in cells treated with either beta minus or alpha-emitting radiopharmaceuticals. The candidate will receive further training in radiochemistry, animal handling, small animal imaging, and radiotoxicology. Additionally, this position offers unparalleled access to opportunities for professional development in areas related to mentoring and scientific communication.

Applicants resumes and qualifications will begin to be reviewed on August 28, 2023

This appointment is fully funded for a year and is extendable for two additional years, contingent on performance and progress during the probationary period. 

Equal Employment Opportunity Statement

All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, citizenship, age, disability or protected veteran status.

Required Degree

Doctorate -Pharmaceutical Sciences, Medical Physics, radiobiology, cancer/cell biology, biochemistry, or related fields

Minimum Requirements

• Applicants should have a Ph.D. degree in pharmaceutical sciences, medical physics, radiobiology, cancer/cell biology, biochemistry, or related fields and an interest in working in tumor radiobiology.
• Ideal candidates should have experience in standard molecular and cellular biology techniques, including but not limited to mammalian cell culturing, western blotting, cell microscopy, PCR, cell cloning, gene transfections, cell survival, flow cytometry, clonogenic assays, and histochemistry.
• Applicants should have experience with data and statistical analysis software like GraphPad.
• Additionally, candidates with previous experience and willingness to work with in vivo tumor models and radioactivity are preferred.
• Competitive Individuals demonstrating a desire to work independently, collaboratively, and in a team environment, strong verbal and written communication skills, and a track record of peer-reviewed publication during Ph.D. training, will be prioritized.

Desired Qualifications

• Ideal candidates should have experience in standard molecular and cellular biology techniques, including but not limited to mammalian cell culturing, western blotting, cell microscopy, PCR, cell cloning, gene transfections, cell survival, flow cytometry, clonogenic assays, and histochemistry, as well as experience with data and statistical analysis software like GraphPad. 

Required Application Materials

cove